This topic contains a solution. Click here to go to the answer

Author Question: Which is NOT an indicator of an effective set of entry criteria? A. A well-designed BSP B. Data ... (Read 31 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
Which is NOT an indicator of an effective set of entry criteria?
 
  A. A well-designed BSP
  B. Data indicating the fidelity of implementing the BSP
  C. A team review of the BSP
  D. Interviews with individuals who have implemented all aspects of the BSP

Question 2

Which of the following is NOT an indicator of an effective instructional approach?
 
  A. Students can relate their learning to their own lives
  B. Students have improved grades in their EBD program classes
  C. Students can describe specific academic gains they are making
  D. Students can discuss the skills they use to reach academic goals



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jessicaduplan

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

D

Answer to Question 2

B




Sufayan.ah

  • Member
  • Posts: 512
Reply 2 on: Jun 20, 2018
Excellent


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Malaria was not eliminated in the United States until 1951. The term eliminated means that no new cases arise in a country for 3 years.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library